BioTrinity Welcome • Stuart Rose, CEO
Keynote: A review of the life sciences investment landscape, with Q&A
Tim Haines
  • Tim Haines (Executive Partner at Abingworth)

    Tim Haines

    Executive Partner at Abingworth
Panel: An Insight into the Macro Environmental Factors Impacting your Business
Keynote: The Humble CEO, What Makes a Winning Mindset
Peter Dines•Emma Thorp
  • Peter Dines (Managing Director of Mercia Ventures)

    Peter Dines

    Managing Director of Mercia Ventures
  • Emma Thorp (Founder & Coach of Thorp Coaching)

    Emma Thorp

    Founder & Coach of Thorp Coaching
Keynote: A Guide to Valuation for Fundraising
Patrik Frei
  • Patrik Frei (CEO of Venture Valuation)

    Patrik Frei

    CEO of Venture Valuation
Networking Lunch
Big Pharma Showcase
Panel: An Insight into how the IRA & BioSecure Act in the US, Impact External Markets
James Fry
  • James Fry (Partner - Head of Life Sciences at Mills and Reeve LLP)

    James Fry

    Partner - Head of Life Sciences at Mills and Reeve LLP
Panel: Working with a CRO to Minimise Risk & Maximise Success
Zoë Johnson
  • Zoë Johnson (M:M Bio)

    Zoë Johnson

    M:M Bio
Keynote: London Stock Exchange, Understanding Market Differences
Tim Davis
  • Tim Davis (Regional Head, UK Primary Markets at London Stock Exchange Group)

    Tim Davis

    Regional Head, UK Primary Markets at London Stock Exchange Group
Keynote: Driving Growth for the UK Life Sciences Sector
Panel: An Insiders Guide to Mergers & Acquisitions
KIRAN GULATI•Damian Marron
  • KIRAN GULATI (Director, Business Operations of New England Biolabs (UK))

    KIRAN GULATI

    Director, Business Operations of New England Biolabs (UK)
  • Damian Marron (Head of Biopharma at Treehill Partners Ltd)

    Damian Marron

    Head of Biopharma at Treehill Partners Ltd
Networking Lunch
Panel: A Review of the Latest Regulatory Updates Impacting R&D SME's
Panel: ESG & Sustainability • How to Change your Business for the Better
CEO Spotlight Session
Jenny Button
  • Jenny Button (Founder and CEO of Emm)

    Jenny Button

    Founder and CEO of Emm

The BioTrinity programme is designed to be relevant, useful & thought-provoking and features three tracks over two-days, which includes:

  • Two Scientific Spotlight tracks, featuring update keynotes and showcase presentations from some of the most exciting R&D companies at series A stage across a range of therapy areas
  • A Business & Investment focused track, featuring keynotes and discussions addressing a broad range of hot topics currently impacting life sciences


CALL FOR SPEAKERS!

Email Jane O'Driscoll if you'd like to be considered for a speaking or presentation opportunity across any of the science or business sessions.  


Click here for a downloadable version of the BioTrinity programme